View in EDS

HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average.

Saved in:
Bibliographic Details
Title: HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average.
Authors: Labban, M1 (AUTHOR), Mali, P1 (AUTHOR), Jao, R1 (AUTHOR), Patel, P1 (AUTHOR)
Source: Value in Health. 2022 Supplement, Vol. 25 Issue 7, pS473-S474. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 157695951
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Labban%2C+M%22">Labban, M</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mali%2C+P%22">Mali, P</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jao%2C+R%22">Jao, R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+P%22">Patel, P</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2022 Supplement, Vol. 25 Issue 7, pS473-S474. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=157695951
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2022.04.966
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S473
    Titles:
      – TitleFull: HPR40 List Prices for Medicare Negotiation-Eligible Medicines Targeted By Build Back Better Drug Pricing Provisions Estimated to be Reduced By over 40% on Average.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Labban, M
      – PersonEntity:
          Name:
            NameFull: Mali, P
      – PersonEntity:
          Name:
            NameFull: Jao, R
      – PersonEntity:
          Name:
            NameFull: Patel, P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 07
              Text: 2022 Supplement
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 10983015
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Value in Health
              Type: main
ResultId 1